These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 10878336)

  • 1. Langerhans cells that have matured in vivo in the absence of T cells are fully capable of inducing a helper CD4 as well as a cytotoxic CD8 response.
    De Creus A; Van Beneden K; Taghon T; Stolz F; Debacker V; Plum J; Leclercq G
    J Immunol; 2000 Jul; 165(2):645-53. PubMed ID: 10878336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal and dermal dendritic cells display differential activation and migratory behavior while sharing the ability to stimulate CD4+ T cell proliferation in vivo.
    Shklovskaya E; Roediger B; Fazekas de St Groth B
    J Immunol; 2008 Jul; 181(1):418-30. PubMed ID: 18566408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dicer-dependent microRNAs control maturation, function, and maintenance of Langerhans cells in vivo.
    Kuipers H; Schnorfeil FM; Fehling HJ; Bartels H; Brocker T
    J Immunol; 2010 Jul; 185(1):400-9. PubMed ID: 20530258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Langerhans cells derived from genetically modified human CD34+ hemopoietic progenitors are more potent than peptide-pulsed Langerhans cells for inducing antigen-specific CD8+ cytolytic T lymphocyte responses.
    Yuan J; Latouche JB; Reagan JL; Heller G; Riviere I; Sadelain M; Young JW
    J Immunol; 2005 Jan; 174(2):758-66. PubMed ID: 15634896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mandatory role of IL-10-producing and OX40 ligand-expressing mature Langerhans cells in local UVB-induced immunosuppression.
    Yoshiki R; Kabashima K; Sakabe J; Sugita K; Bito T; Nakamura M; Malissen B; Tokura Y
    J Immunol; 2010 May; 184(10):5670-7. PubMed ID: 20400709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic treatment with anti-CD40 antibody stimulates Langerhans cell migration from the skin.
    Jolles S; Christensen J; Holman M; Klaus GB; Ager A
    Clin Exp Immunol; 2002 Sep; 129(3):519-26. PubMed ID: 12197894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Freshly isolated Langerhans cells negatively regulate naïve T cell activation in response to peptide antigen through cell-to-cell contact.
    Imai Y; Hayashi N; Yasuda K; Tsutsui H; Mizutani H; Nakanishi K
    J Dermatol Sci; 2008 Jul; 51(1):19-29. PubMed ID: 18367382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral administration of hapten inhibits in vivo induction of specific cytotoxic CD8+ T cells mediating tissue inflammation: a role for regulatory CD4+ T cells.
    Desvignes C; Etchart N; Kehren J; Akiba I; Nicolas JF; Kaiserlian D
    J Immunol; 2000 Mar; 164(5):2515-22. PubMed ID: 10679089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha 6 integrins are required for Langerhans cell migration from the epidermis.
    Price AA; Cumberbatch M; Kimber I; Ager A
    J Exp Med; 1997 Nov; 186(10):1725-35. PubMed ID: 9362532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innate immunity mediated by epidermal keratinocytes promotes acquired immunity involving Langerhans cells and T cells in the skin.
    Sugita K; Kabashima K; Atarashi K; Shimauchi T; Kobayashi M; Tokura Y
    Clin Exp Immunol; 2007 Jan; 147(1):176-83. PubMed ID: 17177977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor gamma inhibits the migration of dendritic cells: consequences for the immune response.
    Angeli V; Hammad H; Staels B; Capron M; Lambrecht BN; Trottein F
    J Immunol; 2003 May; 170(10):5295-301. PubMed ID: 12734379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Langerhans-type dendritic cells genetically modified to express full-length antigen optimally stimulate CTLs in a CD4-dependent manner.
    Yuan J; Latouche JB; Hodges J; Houghton AN; Heller G; Sadelain M; Riviere I; Young JW
    J Immunol; 2006 Feb; 176(4):2357-65. PubMed ID: 16455993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGF-beta 1 prevents the noncognate maturation of human dendritic Langerhans cells.
    Geissmann F; Revy P; Regnault A; Lepelletier Y; Dy M; Brousse N; Amigorena S; Hermine O; Durandy A
    J Immunol; 1999 Apr; 162(8):4567-75. PubMed ID: 10201996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dermal dendritic cells, and not Langerhans cells, play an essential role in inducing an immune response.
    Fukunaga A; Khaskhely NM; Sreevidya CS; Byrne SN; Ullrich SE
    J Immunol; 2008 Mar; 180(5):3057-64. PubMed ID: 18292528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF-beta is required to maintain the pool of immature Langerhans cells in the epidermis.
    Kel JM; Girard-Madoux MJ; Reizis B; Clausen BE
    J Immunol; 2010 Sep; 185(6):3248-55. PubMed ID: 20713882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of functional T cell priming and contact hypersensitivity responses by treatment with anti-secondary lymphoid chemokine antibody during hapten sensitization.
    Engeman TM; Gorbachev AV; Gladue RP; Heeger PS; Fairchild RL
    J Immunol; 2000 May; 164(10):5207-14. PubMed ID: 10799880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human langerhans cells are more efficient than CD14(-)CD1c(+) dermal dendritic cells at priming naive CD4(+) T cells.
    Furio L; Briotet I; Journeaux A; Billard H; Péguet-Navarro J
    J Invest Dermatol; 2010 May; 130(5):1345-54. PubMed ID: 20107482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TIM-4 is differentially expressed in the distinct subsets of dendritic cells in skin and skin-draining lymph nodes and controls skin Langerhans cell homeostasis.
    Zhang X; Liu Q; Wang J; Li G; Weiland M; Yu FS; Mi QS; Gu J; Zhou L
    Oncotarget; 2016 Jun; 7(25):37498-37512. PubMed ID: 27224924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-1 alpha, but not IL-1 beta, is required for contact-allergen-specific T cell activation during the sensitization phase in contact hypersensitivity.
    Nakae S; Naruse-Nakajima C; Sudo K; Horai R; Asano M; Iwakura Y
    Int Immunol; 2001 Dec; 13(12):1471-8. PubMed ID: 11717188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Src homology 2 domain-containing protein tyrosine phosphatase substrate 1 regulates the migration of Langerhans cells from the epidermis to draining lymph nodes.
    Fukunaga A; Nagai H; Noguchi T; Okazawa H; Matozaki T; Yu X; Lagenaur CF; Honma N; Ichihashi M; Kasuga M; Nishigori C; Horikawa T
    J Immunol; 2004 Apr; 172(7):4091-9. PubMed ID: 15034021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.